Leaderboards/Opioid Use Disorder Treatment

Opioid Use Disorder Treatment

Last updated July 7, 2026

Rising Stars

New and hot

Rising Stars Researchers

1
S. Michaela Rikard
National Center for Injury Prevention and Control
2
Lauren J. Tanz
National Center for Injury Prevention and Control
3
Cayley Russell
Centre for Addiction and Mental Health
4
Hossein Khosropour
Isfahan University of Technology
5
Sahan Jayawardana
London School of Economics and Political Science
6
Mimi Pierce
Amsterdam Neuroscience
7
Andrea López
University of Nevada, Las Vegas
8
Tse Yang Lim
Center for Disease Dynamics, Economics & Policy
9
Christopher Dunphy
National Center for Injury Prevention and Control
10
Chengsheng Ju
The London College

Rising Stars Papers

1
Routes of Drug Use Among Drug Overdose Deaths — United States, 2020–2022
MMWR Morbidity and Mortality Weekly Report|2024
110 cit.
2
Detection of Illegally Manufactured Fentanyls and Carfentanil in Drug Overdose Deaths — United States, 2021–2024
MMWR Morbidity and Mortality Weekly Report|2024
56 cit.
3
Drug Overdose Deaths Involving Stimulants ― United States, January 2018–June 2024
MMWR Morbidity and Mortality Weekly Report|2025
27 cit.
4
Temporal and spatial trends of fentanyl co-occurrence in the illicit drug supply in the United States: a serial cross-sectional analysis
The Lancet Regional Health - Americas|2024
18 cit.
5
Gender differences in COVID-19 preventative measures and vaccination rates in the United States: A longitudinal survey analysis
Vaccine|2024
15 cit.
6
The decriminalization of illicit drugs in British Columbia: a national evaluation protocol
BMC Public Health|2024
15 cit.
7
Trends in Naloxone Dispensing From Retail Pharmacies in the US
JAMA|2024
8 cit.
8
Improving Estimates of the Prevalence of Opioid Use Disorder in the United States: Revising Keyes et al
Journal of Addiction Medicine|2024
8 cit.
9
Perceptions and experiences with police among people who use drugs in the initial year of British Columbia's decriminalization of illegal drugs policy
Criminology & Public Policy|2025
7 cit.
10
Use of Heart Failure Medical Therapy Before and After a Cancer Diagnosis: A Longitudinal Study
ESC Heart Failure|2024
3 cit.

Emerging Leaders

Gaining momentum

Emerging Leaders Researchers

1
Nicole L. Davis
Centers for Disease Control and Prevention
2
Lawrence Scholl
Centers for Disease Control and Prevention
3
Ryan McNeil
Yale University
4
Rebecca M. Webster
Webster University
5
Chelsea L. Shover
University of California, Los Angeles
6
Sarah E. Wakeman
Harvard University
7
Jan L. Losby
National Center for Injury Prevention and Control
8
Zachary A. Kasper
Washington University in St. Louis
9
Ketra Rice
Centers for Disease Control and Prevention
10
Marc R. Larochelle
Boston Medical Center

Emerging Leaders Papers

1
Xylazine spreads across the US: A growing component of the increasingly synthetic and polysubstance overdose crisis
Drug and Alcohol Dependence|2022
364 cit.
2
Charting the fourth wave: Geographic, temporal, race/ethnicity and demographic trends in polysubstance fentanyl overdose deaths in the United States, 2010–2021
Addiction|2023
297 cit.
3
Drug Overdose Deaths Among Persons Aged 10–19 Years — United States, July 2019–December 2021
MMWR Morbidity and Mortality Weekly Report|2022
166 cit.
4
Implementation of Safe Supply Alternatives During Intersecting COVID-19 and Overdose Health Emergencies in British Columbia, Canada, 2021
American Journal of Public Health|2022
93 cit.
5
Comparative Effectiveness of Opioid Tapering or Abrupt Discontinuation vs No Dosage Change for Opioid Overdose or Suicide for Patients Receiving Stable Long-term Opioid Therapy
JAMA Network Open|2022
63 cit.
6
The practice and embodiment of “goofballs”: A qualitative study exploring the co-injection of methamphetamines and opioids
International Journal of Drug Policy|2022
46 cit.
7
The Incidence and Disparities in Use of Stigmatizing Language in Clinical Notes for Patients With Substance Use Disorder
Journal of Addiction Medicine|2023
45 cit.
8
Mothers Who Use Drugs: Closing the Gaps in Harm Reduction Response Amidst the Dual Epidemics of Overdose and Violence in a Canadian Urban Setting
American Journal of Public Health|2022
38 cit.
9
Twenty-Year Trends in Drug Overdose Fatalities Among Older Adults in the US
JAMA Psychiatry|2023
37 cit.
10
Predictors of engagement and retention in care at a low-threshold substance use disorder bridge clinic
Journal of Substance Abuse Treatment|2022
35 cit.

Current Senior Leaders

Established & currently active

Current Senior Leaders Researchers

1
Roger Chou
Brown University
2
David S. Metzger
California University of Pennsylvania
3
Thomas Kerr
St. Paul's Hospital
4
John Strang
King's College London
5
David A. Fiellin
Yale University
6
Alexander Y. Walley
Boston University
7
Walter Ling
University of California, Los Angeles
8
Robert N. Jamison
Brigham and Women's Hospital
9
David N. Juurlink
Sunnybrook Health Science Centre
10
Nora D. Volkow
National Institute on Alcohol Abuse and Alcoholism

Current Senior Leaders Papers

1
Management of Postoperative Pain: A Clinical Practice Guideline From the American Pain Society, the American Society of Regional Anesthesia and Pain Medicine, and the American Society of Anesthesiologists' Committee on Regional Anesthesia, Executive Committee, and Administrative Council
Journal of Pain|2016
3.1k cit.
2
Diagnosis and Treatment of Low Back Pain: A Joint Clinical Practice Guideline from the American College of Physicians and the American Pain Society
Annals of Internal Medicine|2007
2.7k cit.
3
CDC Guideline for Prescribing Opioids for Chronic Pain — United States, 2016
MMWR Recommendations and Reports|2016
2.7k cit.
4
Clinical Guidelines for the Use of Chronic Opioid Therapy in Chronic Noncancer Pain
Journal of Pain|2009
2.2k cit.
5
Rates of Hyperkalemia after Publication of the Randomized Aldactone Evaluation Study
New England Journal of Medicine|2004
1.8k cit.
6
CDC Clinical Practice Guideline for Prescribing Opioids for Pain<b>—</b>United States, 2022
MMWR Recommendations and Reports|2022
1.7k cit.
7
The Severity of Dependence Scale (SDS): psychometric properties of the SDS in English and Australian samples of heroin, cocaine and amphetamine users
Addiction|1995
1.3k cit.
8
Cocaine Cues and Dopamine in Dorsal Striatum: Mechanism of Craving in Cocaine Addiction
Journal of Neuroscience|2006
1.2k cit.
9
Medication for Opioid Use Disorder After Nonfatal Opioid Overdose and Association With Mortality
Annals of Internal Medicine|2018
1.1k cit.
10
Medication-Assisted Therapies — Tackling the Opioid-Overdose Epidemic
New England Journal of Medicine|2014
1k cit.

Reagents for Opioid Use Disorder Treatment

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

⭐ Top Rated

Best all-around

Cell Signaling TechnologyEvidence 67

RIP3 (D8J3L) Rabbit Monoclonal Antibody (BSA and Azide Free)

#92131$865
View Evidence →
Cell Signaling TechnologyEvidence 64

IKK epsilon Antibody

#2690$136,317
View Evidence →
Cell Signaling TechnologyEvidence 66

IRF-9 (D9I5H) Rabbit Monoclonal Antibody (BSA and Azide Free)

#74423$865
View Evidence →

🌟 All-Time

Most validated

Cell Signaling TechnologyEvidence 66

FoxO1 (C29H4) Rabbit Monoclonal Antibody (Alexa Fluor® 488 Conjugate)

#58223$183,465
View Evidence →
Cell Signaling TechnologyEvidence 67

Myc-Tag (9B11) Mouse Monoclonal Antibody (Pacific Blue™ Conjugate)

#64584$471
View Evidence →
Cell Signaling TechnologyEvidence 66

Phospho-4E-BP1 (Thr37/46) (236B4) Rabbit Monoclonal Antibody (SignalFlex™ Alexa Fluor® 555 Conjugate)

#74958$486
View Evidence →